Related by context. All words. (Click for frequent words.) 71 TriCo Bancshares Announces 71 XPEL Announces 71 PPD Declares 71 Announces FDA Clearance 70 Completes Enrollment 70 First Patient Enrolled 70 Stereotaxis Announces 69 Receives CE Marking 69 Patient Enrollment 69 Pivotal Clinical Trial 69 Flamel Technologies Announces 69 Profitable Second Quarter 69 Nasdaq Delisting Notice 68 Patients Enrolled 68 Immunomedics Announces 68 Insteel Industries Announces 68 Integra LifeSciences Announces 68 Files IND 68 Ticker Symbol Change 68 Annual Meeting Date 68 Nanophase Announces 68 Phase III Clinical Trial 68 Projected Release Date 68 Announce Merger Agreement 68 Taglich Brothers Initiates Coverage 68 Completes Patient Enrollment 67 Provides Update Regarding 67 Announces Profitable 67 BIOLASE Announces 67 NMT Medical Announces 67 Patient Treated 67 Begins Shipment 67 First Patient Treated 67 Crowflight Announces 67 Wizzard Software Announces 67 CYOE 67 FDA Clears 67 Clinical Trial Results 67 Pivotal Trial 67 Surgery Performed 67 Gets FDA Clearance 67 Initiates Clinical Trials 67 Nymox Reports 66 Receives NASDAQ 66 Initiates Clinical Trial 66 Purported Class 66 KEMET Announces 66 Receives FDA Clearance 66 NDA Submission 66 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 66 BioElectronics Corporation Announces 66 Taro Receives 66 Prostate Cancer Vaccine 66 Announce Collaboration Agreement 66 Receives Orphan Drug Designation 66 Medoro Resources Announces 66 Guidelines Issued 66 Receives Favorable 66 Patent Issued 66 Phase 1b Clinical Trial 66 Pivotal Study 66 NASDAQ Listing Requirements 66 Consolidates Operations 66 Previously Announced Private Placement 66 Updates Guidance 66 Meets Primary Endpoint 66 Submits Application 66 Secures Financing 66 Phase III Trial 66 Granted Orphan Drug 66 Lung Cancer Trial 65 Drug Candidate 65 Announces Stockholder Approval 65 Announces Issuance 65 SulphCo Announces 65 Initiates Clinical 65 Shows Promising 65 Full Face Transplant 65 Significantly Improves 65 Device Maker 65 NYSE Amex Listing 65 ORLive Presents 65 Combination REOLYSIN R 65 Announces Effective Date 65 QHR Announces 65 Biotech Firm 65 Miraculins Announces 65 Mitral Valve Repair 65 Improves Survival 65 Reacquires 65 Flagstone Re Announces 65 Enrolls First 65 Phase 2b Clinical Trial 65 Embolic Protection 65 Patient Enrolment 65 Non Invasive Treatment 65 Bachoco Announces 65 Breast Biopsy 65 Anworth Announces 65 Proxy Proposals 65 NASDAQ Delisting Notice 65 Files Patent Application 65 Announce License Agreement 65 Obtains Exclusive License 65 Less Invasive 65 Initiates Phase II 65 Restructures Debt 65 Demonstrates Significant 65 Advanced Melanoma 65 Issues Clarification 65 Jumps Higher 64 Rotary VAD 64 Board Authorizes 64 Receives Conditional 64 Prostate Cancer Treatment 64 Phase IIb Trial 64 Newmont Declares Regular 64 Initiates Enrollment 64 Regains NASDAQ 64 Surgeons Perform 64 Collaborators Present 64 ViRexx Announces 64 FDA Okays 64 Innovium Announces 64 Nasdaq Deficiency Notice 64 Upcoming Deadline 64 Study Demonstrates 64 Significant Milestones 64 Medicure Announces 64 Announcement acc 64 ANADIGICS Announces 64 FDA Accepts 64 Gout Drug 64 Announce Definitive Agreement 64 Achieves Significant 64 Private Equity Financing 64 Strengthens Balance Sheet 64 FDA Approvals 64 Announces Reverse Split 64 Seasonal Influenza Vaccine 64 Poniard Pharmaceuticals Announces 64 FDA Clearance 64 Confirmatory Phase 64 Clinical Trial Evaluating 64 Consummates 64 Achieves Unprecedented 64 Drug Eluting Coronary Stent 64 Epilepsy Drug 64 Lupus Drug 64 Drug Coated Stent 64 Univest Corporation Declares 64 Clinical Study Shows 64 Announces Definitive Agreements 64 Left Atrial Appendage 64 PDL BioPharma Announces 64 Avcorp announces 64 Nasdaq Notice Regarding 64 Q3 Profit Decreases 64 Receives Notification 64 Complies With 64 Diamyd Medical Diamyd 64 Phase 2b Trial 64 Vertebral Compression Fracture 64 Announces Cancellation 64 Successful Completion 64 Provides Clarification 64 MITTEILUNG UEBERMITTELT VON BUSINESS 64 Successfully Treats 64 Bladex Announces 64 Patient Accrual 64 Milestone Achieved 64 Amends Agreement 64 Subsidiary Enters 63 Demonstrates Positive 63 Closes Previously Announced 63 Shareholders Approve Proposed 63 Updates Shareholders 63 Proves Successful 63 Obtains Approval 63 Study Evaluating 63 Randomized Clinical Trial 63 Patients Treated With 63 Study Shows Benefits 63 Announces Initiation 63 Enters Negotiations 63 Mutually Agree 63 Achieves Milestone 63 Guidelines Recommend 63 Terminate Merger Agreement 63 Biomarker Study 63 Successfully Completed 63 ProChon Biotech 63 Regains Full 63 Receives Orphan Drug 63 Receives Stockholder Approval 63 Receives Favorable Ruling 63 STERIS Corporation Announces 63 Altera Ships 63 Announces Rescheduling 63 Completes Conversion 63 Successfully Completes Phase 63 Lifts FY# Guidance 63 Phase 2a Trial 63 Amend Merger Agreement 63 Receives Milestone Payment 63 Milestone Payment 63 Transplant Patients 63 Announce Commencement 63 Lung Cancer Survival 63 Neoadjuvant Chemotherapy 63 Achieves Primary Endpoint 63 DOR BioPharma Announces 63 Begins Dosing 63 StockSource.us Reports 63 NASDAQ Delisting 63 Prostate Cancer Patients 63 Provides Updates 63 Pending Acquisition 63 Submits NDA 63 Announce Initiation 63 Commence Phase 63 Artificial Cornea 63 Equity Funds Declare 63 Receives SFDA Approval 63 Files Shelf Registration Statement 63 BioSante Pharmaceuticals Announces 63 Teva Provides Update 63 Novel Compounds 63 Confirms Efficacy 63 Asthma Treatment 63 ARRIS Announces 63 Study Validates 63 Significantly Improved 63 Listing Compliance 63 MorphoSys AG FSE MOR 63 Hand Transplant 63 CONMED Corporation 63 Upcoming Investor 63 Aortic Dissection 63 Key Milestones 63 Underscores Commitment 63 Dividend Quick Facts 63 Identifies Potential 63 Expands Internationally 63 Stock Buyback Program 63 IND Filing 63 Misonix Announces 63 Phase IIb Clinical Trial 63 Arthritis Drug 63 Unveils Revolutionary 63 Transplant Recipient 63 Kidney Transplant Patients 63 FDA APPROVES 63 Sign Definitive Agreement 63 Psoriasis Drug 63 PAUL Minn.MN 63 HSR Waiting Period 63 Anticancer Drug 63 Dia Bras Announces 63 Proven Effective 63 Accelerates Growth 63 Begin Clinical Trials 63 NASDAQ Deficiency Notice 63 Oral Calcitonin 63 Closes Financing 63 Vaccine Adjuvants 63 Stem Cell Treatment 63 Migraine Drug 63 Surgical Mesh 63 WebTech Wireless Announces 63 Issues Shareholder 63 Fungal Infections 63 Helps Predict 63 CGGVeritas Announces 63 HCV Protease Inhibitor 63 Announces Ticker Symbol 63 Gerdau Ameristeel Announces 63 Commence Trading 63 Total Knee Arthroplasty 62 Submits Biologics License Application 62 Develop Novel 62 Option Grants 62 Nicotine Vaccine 62 Receives Regulatory 62 Expanded Indication 62 Bioartificial Liver 62 Complete Merger 62 PRAECIS PHARMACEUTICALS INCORPORATED 62 QualityStocks QualityStocks News 62 Initiate Phase III 62 Completes Second Tranche 62 Completes Previously Announced 62 Enters Definitive Agreement 62 Demonstrates Sustained 62 Provides Guidance 62 Remain Listed 62 Rheumatoid Arthritis Drug 62 Approve Merger 62 Announces Postponement 62 Amerigo Announces 62 Drug Fails 62 Enrolling Patients 62 Closes Merger 62 HeartMate R 62 Previously Announced 62 Completes Restructuring 62 Stem Cell Procedure 62 Announces Resumption 62 Recommends Approval 62 Testosterone Patch 62 Hip Implants 62 Sign Licensing Agreement 62 Tissue Engineered 62 Improve Survival 62 Finalizes Acquisition 62 DTC Eligibility 62 Patients Treated 62 REPORTS FIRST QUARTER 62 Inhaled Insulin 62 Could Save Lives 62 NLTX 62 Double Blind Placebo 62 Re Affirms 62 Heart Failure Patients 62 Sign License Agreement 62 Minimally Invasive Procedure 62 Resume Trading 62 JAK2 Inhibitor 62 Significant Milestone 62 Executes Definitive 62 Atwood Oceanics Announces 62 Transplant Patient 62 Develops Novel 62 Coronary Revascularization 62 Recurrent Prostate Cancer 62 Being Studied 62 includes Dideco CarboMedics 62 Patented Technology 62 Celebrates Successful 62 Patent Covering 62 Uterine Fibroid Embolization 62 Nasdaq Delisting Notification 62 Terminate Merger 62 Geokinetics Announces 62 Clinical Trial Enrollment 62 Clinical Evaluation 62 Aneurysm Repair 62 Announce Shareholder Approval 62 Completes Reverse Merger 62 Localized Prostate Cancer 62 Underwritten Public 62 Artificial Liver 62 Gentex Declares Quarterly 62 Breakthroughstocks.net EXPLOSIVE news 62 Completes Patient Enrolment 62 Announce Completion 62 Audited Financials 62 Strengthen Balance Sheet 62 BioElectronics Announces 62 Evergreen Closed End 62 TRANSDUR ™ 62 Successfully Concludes 62 Patients Undergoing 62 Announces Divestiture 62 Terminates Agreement 62 Prostate Surgery 62 Receives Funding 62 Severe Sepsis 62 Lung Cancer Drug 62 Image Guided 62 Receives Patent 62 Abstract Accepted 62 Device Helps 62 Accredits 62 Kreisler Manufacturing Corporation 62 Completes Dosing 62 Stock Buyback Plan 62 Announce Early Termination 62 Nasdaq Listing Requirements 62 Minimally Invasive Treatment 62 Implantable Device 62 Debt Tender Offers 62 Ovarian Cancer Treatment 62 Patents Issued 62 Increases Stock Buyback 62 AVI BioPharma Announces 62 Patent Infringement Lawsuit 62 Advanced Heart Failure 62 Molecular Diagnostic Test 62 Bone Grafting 62 Gene Variants 62 Receives Conditional Approval 62 VIVUS Announces 62 Phase Ib Clinical Trial 62 Balance Sheet Restructuring 62 Single Dose 62 Bone Metastases 62 Receives ISO #:# [002] 62 PDUFA Date 62 EntreMed Presents 61 Unveils Groundbreaking 61 Spectrum Pharmaceuticals Announces 61 Clinical Trial Data 61 Boosts Buyback 61 SABESP Announces 61 Absorbable 61 Adjuvant Treatment 61 OTCBB ILNS 61 REPORTS THIRD QUARTER 61 Face Transplant 61 Lupatech BMF & 61 Study Evaluates 61 Milestone Reached 61 REMINDER ORLive Presents 61 Acute Heart Failure 61 Acquire Assets 61 LightPath Technologies Announces 61 liver resection surgeries 61 Announces Stock Buyback 61 Trial Evaluating 61 IND Application 61 Successfully Closes 61 APA ots news 61 Islet Transplantation 61 An Opportunity Awaits 61 Wholly owned Subsidiary 61 Topline Results 61 Loan Funds Declare 61 Completes Financing 61 Announces Definitive Agreement 61 GRAS Status 61 Renal Cancer 61 Pending Merger 61 Lorus Therapeutics Announces 61 Summarizes 61 Licenses Novel 61 Private Placement Financings 61 Newly Identified 61 Aortic Valve Replacement 61 Pennichuck Corporation Announces 61 Presents Positive 61 Largest Database 61 Continues Aggressive 61 Exclusive License 61 Plaque Psoriasis 61 FDA Approves Drug 61 Preclinical Data 61 Announces Underwriters Exercise 61 Mylan Receives Approval 61 OMRIX Biopharmaceuticals 61 Cavitation Technologies 61 Beta Blocker 61 Gastar Exploration Announces 61 Fat Grafting 61 Annual Repurchase Offer 61 Curon Medical 61 Expand Collaboration 61 Breast Cancer Recurrence 61 PLEASE READ THE FOLLOWING 61 COMPLETES ACQUISITION OF 61 Announces Poster Presentations 61 Boosts Productivity 61 Imaging Technique 61 FY# Loss Widens 61 Initiates Phase III 61 Bovie Medical Corporation 61 DuraHeart TM 61 Prolongs Survival 61 Receives Positive 61 Files Investigational 61 Streamlines Operations 61 5RTI 61 Mass.MA 61 Announce Expiration 61 Announce Receipt 61 Spinal Implant 61 Authorizes Share Repurchase 61 Breast Tumor 61 Hepatitis C Treatment 61 Therapeutic Competitors Companies 61 Controlled Study 61 Symptom Relief 61 Nuvelo Announces 61 Receives Approvable Letter 61 Laryngeal Cancer 61 Articular Cartilage 61 Biomerix Corporation 61 Resistant Hypertension 61 Ebola Vaccine 61 Carotid Stenting 61 Announces Licensing Agreement 61 Investigational Agent 61 Heart Failure Treatment 61 Stent Coating 61 Liver Failure 61 Submits Revised 61 Vascular Grafts 61 FDA Panel Recommends 61 WORLDWIDE INC. 61 Smallpox Vaccine 61 Extends Collaboration 61 Announces Termination 61 Sagent Pharmaceuticals Announces 61 Clinical Outcome 61 Successfully Treated 61 II Clinical Trial 61 Patent Infringement Suit Against 61 Obtains Financing 61 Headwaters Incorporated Announces 61 Issued Patent 61 Initiates Dosing 61 Prostate Tumors 61 Microwave Ablation System 61 Myrexis Inc. 61 Randomized Controlled Trials 61 Strengthens Leadership 61 Prove Effective 61 Testosterone Gel 61 Proves Effective 61 Randomized Clinical Trials 61 PROMUS R 61 Systemic Delivery 61 Vertebral Fracture 61 Gastric Cancer 61 PHAZAR CORP Announces 61 Shows Promise Against 61 Carotid Artery Stenting 61 Implant Sciences Announces 61 Stent Placement 61 Heart Transplantation 61 AMPLATZER R 61 Oral Fingolimod 61 Randomized Study 61 Reconfirms 61 Hematopoietic Stem Cell Transplantation 61 J.P. Morgan Healthcare 61 Gentium Announces 61 Combination Treatment 61 Pluristem Therapeutics 61 Cholesterol Lowering Drug 61 Dividend Declared 61 BFRM 61 PATHFINDER ® TRACER 61 Non Invasive 61 Initial Shipment 61 Gene Variation 61 ISSI Announces 61 CybeRelease OTC 61 Obtains CE Mark 61 Its Previously Announced 61 Sirolimus Eluting Stent 61 Dual Listing 61 Minimally Invasive Therapy 61 OTCQX QRXPY 61 Extends Tender Offer 61 Over Allotment Option Exercised 61 Osteoporosis Treatment 61 Significantly Expand 61 Vaccine Adjuvant 61 Enhance Shareholder Value 61 Demonstrates Potential 61 Pernix Therapeutics 61 Selects BoardVantage 61 Present Preclinical Data 61 Merger Discussions 61 Drug Shows Promise 61 Slows Progression 61 Announces Presentation 61 Board Unanimously Rejects 61 Lung Cancers 61 Effectively Treats 61 ENFORCEMENT PROCEEDINGS 60 Receive Milestone Payment 60 Prognostic Value 60 Announces Share Buyback 60 Restructures Operations 60 Weight Loss Drug 60 Schizophrenia Drug 60 Enters Into Collaboration 60 Recurrent Breast Cancer 60 Completes Due Diligence 60 Completes Tender Offer 60 Eur J 60 Sangamo BioSciences Announces 60 Dural Regeneration Matrix 60 Subsidiary Receives 60 Data Suggest 60 Receives Unsolicited 60 For Undisclosed Terms 60 ZTEST Announces 60 Patent Broadly Covering 60 Osteoporosis Drugs 60 Third Quarter Dividend 60 Stockholders Approve Merger 60 Announces Conditional Approval 60 Recommends Acceptance 60 Strongly Supports 60 ISTO Technologies 60 ANNOUNCES FOURTH QUARTER 60 Cyclacel Pharmaceuticals 60 BioSante Pharmaceuticals Reports 60 InterOil Announces 60 Total Hip Arthroplasty 60 Announces Successful Completion 60 Knee Implant 60 Patent Infringement Litigation 60 Oral Interferon 60 Develops Innovative 60 NASDAQ CYTX 60 Unsolicited Tender Offer 60 Novel Antibiotic 60 Osteoporosis Drug 60 Receives CE 60 Improved Survival 60 Improves Outcomes 60 Deregister 60 Confirms Commitment 60 OTC MNDP 60 Terminates Contract 60 Randomized Trials 60 Cell Transplants 60 #M Buyback [001] 60 Response Biomedical Corporation 60 OTCBB ZERO 60 Mechel Announces 60 Private Placement Closed 60 MBMI Closes 60 Major Step Toward 60 Undisclosed Investors 60 Director Shareholding 60 Announce Licensing Agreement 60 HER2 Positive 60 FINANCIAL GUIDANCE 60 Pivotal Phase 60 Expert Discusses 60 Holds Successful 60 Drug Coated Stents 60 Female Urology 60 MorphoSys AG MorphoSys 60 Substantially Reduce 60 Daxor Announces 60 Hernia Repair 60 ONI BioPharma Inc. 60 Filing Status 60 Hosting Firm 60 Preterm Labor 60 Spinal Fusion 60 Receives Accreditation 60 Prospective Randomized 60 Presents Preclinical Data 60 #M Stock Buyback 60 Buy Privately Held 60 Increases Share Repurchase 60 Gendux AB 60 Antimicrobial Coating 60 AUDIO PROVIDED BY 60 Milestone Payments 60 Test Detects 60 Resubmission 60 Novel Oral 60 Multi Billion Dollar 60 Sees Steady 60 Announces Record Date 60 Trading Volumes 60 REPORTS RECORD 60 Luna Innovations Announces 60 Completes Private Placement 60 Develop Next Generation 60 Receives Clearance 60 Common Share Repurchase Program 60 PRNewswire FirstCall HeartWare 60 Shareholder Meeting Date 60 Lowers Risk 60 Imagenetix Inc. 60 Corneal Transplant 60 CT Angiography 60 Phase IIa Clinical Trial 60 Underwriters Exercise 60 Protherics PLC announces 60 Hematological Malignancies 60 Nasdaq AVNC 60 Novel Vaccine 60 Breast Ultrasound 60 Expands Capabilities 60 Multicenter Trial 60 Cardiac Resynchronization Therapy 60 Artificial Skin 60 Sitebrand Announces 60 Ventricular Assist Device VAD 60 Commences Phase 60 Announces Operational Update 60 Hematology Molecular Pathology 60 Robotic Assisted 60 Source Victhom Human 60 Contrast Agent 60 Finalizes Agreement 60 Initiate Clinical Trial 60 Content Outline 60 Cervical Dysplasia 60 Engages CHF Investor Relations 60 Enters Into Agreements 60 Cervical Spine 60 Cholesterol Lowering 60 Definitive Merger Agreement 60 Flagship Product 60 Ramco Gershenson Announces 60 HEICO Corporation 60 Inhaled Nitric Oxide 60 Successfully Tested 60 Endovascular Treatment 60 Anti CD# Antibody 60 Announces Rebranding 60 Valve Replacement 60 Node Positive 60 Female Stress Urinary 60 Tuberculosis Vaccine 60 Relocates Corporate Headquarters 60 Regulatory Approvals 60 Prenatal Screening 60 Phase 2a Clinical Trial 60 Delcath Phase III 60 Pooled Analysis 60 ™ Paclitaxel Eluting 60 Fancamp Announces 60 ITH Intl 60 Glaucoma Treatment 60 Regenerative Cells 60 Updates Status 60 TELEPERFORMANCE 60 Antiviral Drugs 60 Finalizes Joint Venture 60 Obese Patients 60 Brain Metastases 60 TOP Ships Announces 60 Endovascular Repair 60 Obese Teens 60 Acacia Subsidiary 60 IRIDEX Announces 60 Topical Treatment 60 Generic Version 60 Receives Commitment 60 Completes Divestiture 60 Tezampanel 60 Clarifies Status 60 Quarterly Dividends 60 Multicenter Phase 60 Reports Positive 60 Temoris Resources Inc. 60 Drug Combo 60 Expands Scope 60 Pulmonary Artery 60 Cardiac Rhythm 60 Anti Inflammatory Drug 60 #.#/Share [002] 60 ThermoGenesis Announces 60 Statin Therapy 60 Relapsed Multiple Myeloma 60 Smooth Muscle 60 Submits Response 60 Share Repurchases 60 External Defibrillators 60 Envirokare Tech Inc. 60 Appears Safe 60 Pharmacyclics Announces 60 Frankfurt XMP 60 Receives Fast Track 60 Pharmos Corporation 60 Could Revolutionize 60 AvalonBay Communities Announces 60 #M MarketCap [001] 60 Being Evaluated 60 Patent Lawsuit 60 Prospective Multicenter 60 Unitholders Approve 59 Hiru Corporation HIRU 59 Cell Transplant 59 Has Been Awarded 59 Voluntary Delisting 59 Therapeutic Competitors companiesandmarkets.com adEgemonye 59 Share Buyback Program 59 Settle Patent Litigation 59 Breast Carcinoma 59 Increases Ownership 59 Receives Approvals 59 Transcept Pharmaceuticals 59 Important Milestone 59 Enters Into Definitive 59 Tenn.TN 59 Combo Therapy 59 Broadens Its 59 Endometrial Cancer 59 Share Issuance 59 Guidance Reaffirmed 59 Ischemic Stroke 59 Debt Refinancing 59 Announces Consummation 59 Improve Diagnosis 59 Dose Ranging Study 59 Japanese Stocks Climb 59 Anti Clotting Drug 59 Myoblast 59 Tremendous Growth 59 Meningitis Vaccine 59 Inc. OTCBB IMDS 59 GATTEX TM 59 Identifies Key 59 Announces Granting 59 Flexpoint Announces 59 Diabetic Foot Ulcer 59 Heart Transplant Recipients 59 Regeneron Pharma 59 Settles Litigation 59 Gets Clearance 59 Anticancer Activity 59 VIVITROL ® 59 AMEX RGN 59 Surgical Treatment 59 Male Contraceptive 59 Minimally Invasive Spine Surgery 59 Files Formal 59 injectable bulking agent 59 Mln Share Buyback 59 Significantly Increases 59 Completes Transaction 59 Interferon Alpha 59 Anticancer Agent 59 Pivotal Phase III 59 Successfully Demonstrates 59 Novel Mechanism 59 InternetArray Noobis 59 Surpasses Expectations 59 Schizophrenia Treatment 59 Completes Initial 59 Endeavor Drug Eluting 59 Spirus Medical 59 Issues Guidance 59 Breaks Barriers 59 Patent Infringement Suit 59 RELM Holdings 59 Inks MOU 59 Inovio Pharmaceuticals 59 Develop Innovative 59 Receives Authorization 59 Sunesis Pharma 59 Hana Mining Announces 59 Regulatory Clearance 59 Separate Conjoined Twins 59 CHMP Opinion 59 Tyrosine Kinase Inhibitor 59 Investigational Treatment 59 Fourth Quarter Cash Dividend 59 Antitrust Clearance 59 BioLife Solutions 59 Reduces Risk 59 Chronic Heart Failure 59 Completes Expansion 59 Approves Share Repurchase 59 Therapeutic Vaccine 59 Enters Into Definitive Agreement 59 News Unternehmensnachrichten DGAP Adhoc 59 Predict Risk 59 Receives Marketing Authorization 59 OTCBB IMUC 59 Preclinical Study 59 External Beam 59 Receives Tentative Approval 59 Cholesterol Drug 59 Novel Inhibitor 59 Slow Progression 59 Bone Marrow Transplants 59 Wafer polifeprosan 59 Diagnostic Tests 59 Cardiovascular Therapeutics 59 Gene Linked 59 Influenza Vaccine Production 59 Receives Shareholder Approval 59 Kidney Transplants 59 Announces Commencement 59 Submits IND 59 Announces Tentative Approval 59 Supplemental Biologics License Application 59 Cardiac Ablation 59 Strategic Alternatives Process 59 Adenoma 59 Immune Cell 59 Dry Powder Inhalers 59 Acquire Remaining 59 OVIT 59 Orthopedic Implant 59 PayChest Inc. 59 Hsp# Inhibitor 59 Electrophysiology Mapping 59 Voluntary Withdrawal 59 TB Vaccine 59 Randomized Phase III 59 Adjunctive Therapy 59 Closes Oversubscribed 59 Aggressive Prostate Cancer 59 Hepatitis B Vaccine 59 Process Automation Solution 59 Feds Approve 59 Spinal Disc 59 Review Initiated 59 Gentamicin Surgical Implant 59 Proc Am Soc 59 Confirms Receipt 59 Obtains Patent 59 Antitumor Activity 59 Initiates Phase 2b 59 Inc. Nasdaq HTWR 59 Finalizes Purchase 59 Acquire Controlling Stake 59 Previously Announced Acquisition 59 Blood Pressure Drug 59 Metabasis Therapeutics 59 Treatment Reduces 59 Intertainment Itibiti Systems 59 Receives Complete Response 59 Vertebral Fractures 59 Accelerate Commercialization 59 Malpractice Suit 59 Conditional Approval 59 Adjuvant Chemotherapy 59 Poster Presentations 59 Convertible Debenture Financing 59 Renal Artery 59 com BlackSingles.com R 59 Oncologic 59 CRYO 59 First Patient Dosed 59 OTCBB ARDM 59 Lawsuit Involving 59 Demonstrates Ability 59 FIRST QUARTER RESULTS 59 Completes Successful 59 Contract Signings 59 Newly Merged 59 Cosmetic Procedure 59 Drug Eluting Stent System 59 Formalizes 59 Closes Second Tranche 59 Study Pinpoints 59 Arbitration Proceedings 59 Seminar Focuses 59 Transdermal Patch 59 Vantex Completes 59 Internationally Recognized 59 Injection Site 59 Multicenter Randomized 59 Liver Tumors 59 Acquires Controlling Interest 59 Regenerative Cell 59 Demonstrates Statistically Significant 59 Vascular Graft 59 Patent Upheld 59 Milestone Payment From 59 Provides Detailed 59 Reveals Significant 59 Subsidiary Expands 59 Transcatheter 59 Closes Over Allotment 59 AND FINANCIAL SERVICES 59 PET Scanner 59 Study Showed 59 Stereotactic Body Radiation Therapy 59 Antithrombin 59 Commences Initial 59 Initiates Voluntary 59 Earns Milestone Payment 59 BROADCOM CORP. Broadcom 59 Artery Disease 59 Announces Intent 59 Acute Decompensated Heart Failure 59 Renegotiates 59 Proposed Offering 59 Inc. OTCBB CADM 59 Hematological Cancers 59 OTCBB UVFT 59 Reduces Pain 59 Marks Milestone 59 Lumbar Spine 59 COMUNICADO DE 59 Showed Significant 59 Ophthalmic Drug 59 Cardioxyl Pharmaceuticals 59 Concludes Successful 59 Proposed Private Placement 59 Successful Conclusion 59 Chemotherapy Regimen 59 ST Elevation Myocardial 59 Male Infertility 59 Announces Debt Settlement 59 Catheter Ablation 59 Statin Drugs 59 Bioresorbable 59 Enzo Biochem Reports 59 Preliminary Injunction Against 59 Reseller Relationship 59 Arch Biopartners